We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug & Device Products
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Publications
    • Webinar Training Pass
    • eCFR and Guidances
    • Books
  • Clinical Products
  • Advertising
  • White Papers
  • Contact Us
  • About Us
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Store » Device Products » The CDRH Reorganization - Webinar Recording/Transcript

Other Options

Audio Recording/Transcript - Feb. 14, 2018

$287.00

Audio Recording/Transcript - Feb. 14, 2018

$258.00

Audio Recording/Transcript - Feb. 14, 2018

$244.00

Audio Recording/Transcript - Feb. 14, 2018

$230.00

Audio Recording/Transcript - Feb. 14, 2018

$215.00

The CDRH Reorganization - Webinar Recording/Transcript

$287.00
Device Products

Product Details

The CDRH Reorganization: Managing Total Product Life Cycle, Real World Evidence, and Digital Health Policies

Device regulation is about to change in ways large and small, as the CDRH moves toward a total reorganization.

After it’s complete, the principal medical device overseer is expected to take a total product life-cycle (TPLC) approach, whereby postmarket realizations are fed back into premarket data requirements.

It behooves you to understand the new structure and how it will affect you.

Paul Gadiock Esq., formerly Associate Director for Policy at the CDRH and now a Senior Attorney at Arent Fox LLP, shares insider knowledge in a session that’s a must for every FDA-regulated devicemaker. Here’s what you’ll learn:

  • The right office to contact after the reorganization — not too high, not too low
  • The right way to frame your case: Making the most persuasive argument.
  • The background: Lessons learned from similar reorganizations at CDER and CDRH/OIR
  • How CDRH regulatory policies, such as the TPLC, Real World Evidence and Digital Heath, influenced the CDRH reorganization
  • Impact of current high-level Center vacancies
  • How reorganization may affect CDRH interplay with other FDA bureaus
  • And much more!

The CDRH enforces the rules you live under. Knowing who to contact post-reorganization, and best ways to make your case, is priceless information. It’s well worth 90 minutes of your time to get an advance look at this fundamental change to your regulatory landscape.

  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell My Personal Information
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Fax 703.538.7676 – Toll free 888.838.5578

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing